There is high consensus among the SCMs that histological grade, histological type, nodal involvement, tumour size, Ki-67 labelling index, and genomic signatures are important factors that influence the risk of relapse of surgically resected HR+/HER2-negative eBC (Statement No. 29). Here, ERBB2 is linked to neoplasm.